Twitxy Saved

Pasquale Paolisso

Verified account This account is verified. Learn more

@P_Paolisso

MD, PhD, FESC |Cardiovascular Center Aalst, Belgium🇧🇪 |Cardiology, Sant'Andrea University Hospital, Rome, Italy🇮🇹|SoMeTeam #improvingHeartFunction
Joined October 2020
4.1K Following 3.2K Followers 578 Posts

Latest posts 5

Pinned post

Pasquale Paolisso Verified account @P_Paolisso
Our State-of-the-Art Review on Multimodality Imaging in the Diagnostic Work-Up of Patients With Cardiac Masses is now out on @JACCCardioOncology @JACCJournals 👇
sciencedirect.com/science/articl…

Role of current multimodality imaging and future directions for their applications:
👥For whom and when?
🔎What to look for?
💪Strengths and weaknesses
💥Latest advances
🔥Tips and tricks

📨Key Message
🟢Echo is typically the initial imaging modality
🧲CMR is recognized as the diagnostic gold standard.
🔁CCT provides complementary.
☢️PET serves as a 3-level imaging option.
#echofirst #WhyCMR #Multimodalityimaging #Cardiology #CardiologyNews
3 replies 67 reposts 184 likes 17K views View on X
Pasquale Paolisso Verified account @P_Paolisso
🔥New in #JACC: Basic to Translational Science -Simultaneously published at #ESCCongress2026
"SGLT2i and Molecular Signatures of Aortic Valve Remodeling in Severe #AorticStenosis: The Valve-AS Study"

To date, no drug has been shown to slow calcific AS progression. Could SGLT2 inhibitors change that?

Using transcriptomics, ELISA, and MALDI imaging, we found that SGLT2i were linked to:
⬇️ valvular SGLT1/2, GLUT4, and NHE expression
🔀 A metabolic shift - ↑PPARα, ↓PPARγ
⬇️ inflammation (↓NF-κB, ↓IL-6)
⬆️ antioxidant SOD2
⬇️ fibrocalcific remodeling enzymes MMP-9/12
🔄 A distinct metabolomic signature - enriched amino acid, purine, and redox pathways - visualized spatially across the valve tissue.

These findings suggest SGLT2i may reprogram the valve's microenvironment, offering the first mechanistic rationale for a disease-modifying drug in AS!

📄 Read the full study👇: doi.org/10.1016/j.jacb…

#Cardiology #AorticStenosis #SGLT2inhibitors #Metabolomics #Cardiovascular #Research #ESC2026
Pasquale Paolisso Verified account @P_Paolisso
🚨1/ New in @ESC_Journals European Heart Journal: Micro & nanoplastics (MNPs) are detectable in the human coronary circulation and are higher in acute MI.

🔥2/ In patients undergoing coronary angiography, MNPs were found in 84.2% of STEMI vs 40% of chronic coronary syndromes & 31.8% of controls (P=.002), with higher concentrations & greater polymer diversity in STEMI. Polyethylene predominated (97%).

🔥3/ MNP detection co-occurred with ↑IL-6 & TNF-α, greater chronic PM2.5 exposure & smoking. Smoking was an independent predictor of MNP presence (OR 5.69). MNP detection independently predicted obstructive CAD.

🎯4/ A call to action to reduce exposure to MNPs, highlighting the cardiovascular exposome as an emerging frontier in cardiovascular risk.

👉Micro- and nano-plastics in the coronary circulation and air pollution exposure in ischaemic heart disease presentation academic.oup.com/eurheartj/arti…

#Cardiology #MicroplasticsAndHealth #AirPollution #STEMI #CardiovascularDisease #Exposome #EuropeanHeartJournal #ESC
0 replies 9 reposts 12 likes 1.1K views View on X
Pasquale Paolisso Verified account @P_Paolisso
🚨🚨 New article collection in #CardiovascularDiabetology @BioMedCentral

💥“Incretin-Based Therapies in Type 2 Diabetes and Obesity: Current Evidence and the Evolving Cardiometabolic Landscape”

Exploring the latest evidence on GLP-1 receptor agonists, dual incretin therapies, obesity management, and cardiometabolic outcomes.

👉Explore the collection here: bit.ly/3NnPXXd

💥“Cardiovascular-Kidney-Metabolic (CKM) Syndrome: Risk Stratification, Prognostic Implications and Therapeutic Innovation”

Highlighting emerging evidence on CKM syndrome, integrated risk assessment, and novel therapeutic strategies across cardiovascular, renal, and metabolic disease.

👉Explore the collection: bit.ly/4kQoycS

#CKM #Cardiology #Nephrology #Diabetes #CardioRenalMetabolic #PrecisionMedicine #CardiovascularResearch #Cardiology
#Obesity #CardioMetabolic #GLP1 #Endocrinology